N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
Critically ill patients frequently undergo contrast enhanced computed tomography (CT) to establish diagnoses and direct management. Contrast agents can disturb kidney function and result in kidney dysfunction. The investigators investigated the effects of high dose N-acetylcysteine (NAC) or placebo, in addition to hydration, in preventing kidney dysfunction following contrast enhanced CT) in critically ill adults in the intensive care units of two teaching hospitals.
Epistemonikos ID: 937b8f6d2a91d36f855ccd243fe54d9e0b7cd0be
First added on: May 05, 2024